MktsMarkets

Rhythm Pharmaceuticals, Inc.
NASDAQ: RYTMKey statistics
RYTM News
Stories mentioning RYTM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 60,112 | 57,253 | 51,298 | 48,502 | 32,704 | 41,830 | 33,251 | 29,078 |
| Cost of Goods Sold | 7,157 | 4,802 | 5,499 | 5,543 | 3,648 | 3,786 | 3,828 | 2,947 |
| Gross Profit | 52,955 | 52,451 | 45,799 | 42,959 | 29,056 | 38,044 | 29,423 | 26,131 |
| Operating Expenses | ||||||||
| Research & Development | 41,725 | 42,032 | 46,027 | 42,308 | 36,973 | 41,167 | 37,931 | 30,194 |
| Sales General & Admin | 63,591 | 57,482 | 52,425 | 45,947 | 39,087 | 38,130 | 35,377 | 36,415 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (52,361) | (47,063) | (52,653) | (45,296) | (47,004) | (41,253) | (43,885) | (40,478) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (1,704) | 58.00 | 274.00 | 1,576 | (644.00) | 325.00 | 1,088 | 302.00 |
| Pretax Income | (55,094) | (47,536) | (52,793) | (46,295) | (49,418) | (43,417) | (43,985) | (31,782) |
| Tax Provision | 545.00 | (31.00) | 111.00 | 337.00 | 80.00 | (89.00) | (344.00) | 479.00 |
| Net Income (Loss) | (55,639) | (47,505) | (52,904) | (46,632) | (49,498) | (43,328) | (43,641) | (32,261) |
| Earnings Per Share (Basic) | (0.83) | (0.73) | (0.82) | (0.75) | (0.81) | (0.71) | (0.73) | (0.55) |
| Earnings Per Share (Diluted) | (0.83) | (0.73) | (0.82) | (0.75) | (0.81) | (0.71) | (0.73) | (0.55) |
| Weighted Average Shares Outstanding (Basic) | 67,974 | 64,984 | 66,261 | 63,684 | 63,059 | 60,995 | 61,220 | 61,012 |
| Weighted Average Shares Outstanding (Diluted) | 67,974 | 64,984 | 66,261 | 63,684 | 63,059 | 60,995 | 61,220 | 61,012 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RYTM
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a stock listed on the Nasdaq Stock Market under the ticker symbol RYTM. It last traded at $89.47 (Oct 26, 2026, 4:00 PM ET), up 0.2% on the day. That gives Rhythm Pharmaceuticals a market capitalisation of $6.2B.
Over the past 52 weeks RYTM has traded between $74.50 and $122.20.
Revenue for the quarter ended Mar 31, 2026 was $60.1M; a net loss of $55.6M. Revenue was up 83.8% from $32.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $60.1M | -$55.6M | -92.6% |
| Dec 31, 2025 | $57.3M | -$47.5M | -83.0% |
| Sep 30, 2025 | $51.3M | -$52.9M | -103.1% |
| Jun 30, 2025 | $48.5M | -$46.6M | -96.1% |
From Rhythm Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…